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Anxiety is a natural reaction to stress.  However, when anxiety becomes excessive it can 
develop into a debilitating disorder.  Interventions are needed to ameliorate and prevent the 
development of anxiety related health disorders.  Casual video games (CVGs) are fun, easy to 
play, spontaneous, and extremely popular.  In this randomized controlled study the efficacy of 
CVGs in reducing symptoms of anxiety in a depressed population was tested by comparing 
individuals in the experimental group, who were prescribed a CVG to utilize over a one month 
period, with a no-treatment control group.  The methodology included participants in the 
experimental group playing a CVG three times a week for 30 minutes each session, over a 
one-month period.  The State Trait Anxiety Inventory (STAI) was used to measure participants’ 
state and trait anxiety pre-post intervention.  Results from both state and trait measures 
demonstrated that the intervention was effective in reducing state and trait anxiety symptom 
severity scores for the experimental group when compared to the control group.  These findings 
demonstrate the use of prescriptive interventions that utilize CVGs as a way to treat anxiety, as 
well as, implications that include the potential expansion of applications of CVGs as an adjunct 
to medicine and other medical therapies being utilized alone
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  CHAPTER I:  INTRODUCTION 
 
Background 
Anxiety is a paradoxical phenomenon.  On the one hand it is a normal reaction typically 
brought about by a stressor or some form of danger (Butcher, Mineky, & Hooley, 2007).  
Anxiety serves as a coping mechanism in this respect helping some people with stressful 
experiences.  On the other hand, anxiety disorders develop when anxiety becomes excessive or 
uncontrollable.  Anxiety can then become detrimental to overall daily functioning and health.  
This can lead to impairments in cognitive, physiological, and behavioral states.  Some common 
symptoms experienced with anxiety include negative mood, unnecessary worry, loss of control, 
chronic stress and tension, and avoidance of specific situations or environments (Butcher et al., 
2007; National Institutes of Mental Health, 2010a).   
Anxiety prevalence statistics estimate that anxiety disorders affect approximately 40 
million Americans (National Institutes of Mental Health, 2009).  The National Comorbidity 
Survey (NCS) found that lifetime and 12-month prevalence for any anxiety disorders was 24.9% 
and 17.2% (Belzer & Schneier, 2004).  In the United States general population, approximately 
40 million (18.1%) adults have an anxiety disorder (National Institute of Mental Health, 2010b).  
Anxiety disorders are the most commonly diagnosed psychological disorders among women and 
are the second most prevalent for men.  In a recent study, it was observed that at least one form 
of an anxiety disorder was experienced over a 12-month period by approximately 23 percent of 
women and 12 percent of men (Himle, Raymond, Taylor, Campbell, & Jackson 2009).   
Current healthcare treatments for anxiety are limited and costly, creating a need for 
effective and affordable interventions (Kasper, Boer, & Sitsen, 2003).  Generally, individuals 
diagnosed with anxiety receive medication, psychotherapy, or a combination of the two (Barlow, 
2004).  Medications are sometimes viewed as the cure all for anxiety.  However, it is 
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suggested that medications should be used collaboratively with psychotherapy (National 
Institutes of Mental Health, 2009).  Relapse rates for these forms of treatment are high 
(National Institutes of Mental Health, 2009).  Furthermore, medications can lead to a variety of 
side effects that can be detrimental to an individual’s quality of life (Kasper et al., 2003).  
Dosage must be continually increased to achieve the same therapeutic effect, forcing patients to 
take increased amounts of medications. Such dilemmas can create unhealthy and problematic 
issues, such as chemical dependencies, which can complicate and/or delay the rehabilitation 
process.  Psychotherapy and medications tend to be expensive and can create financial 
challenges for patients (National Institutes of Mental Health, 2009).  Thus there is a need for 
cost effective efficacious treatments for anxiety disorders. 
More recently, other non-pharmacological treatments have begun to be studied as 
potential treatments.  For instance, in a recent randomized-controlled research study, with 
non-diagnosed anxious participants, it was demonstrated that individuals who played Casual 
Video Games (CVGs) when compared to control subjects with similar conditions elicited 
increased positive mood and decreased stress (Russoniello, O’Brien, & Parks, 2009).  The 
Casual Games Association (2007) defines CVGs as fun, fast to access, simple to learn and 
require no previous video game skills or time commitment to play.  Casual Video Games can be 
played in small time increments because they are easy to pause, stop, and restart at any time.  
Results from the study established changes in electroencephalography (EEG), a measure of 
electrical activity recorded from the brain, consistent with improved mood and positive changes 
in heart rate variability (HRV), a physiological measure that records autonomic nervous system 
(ANS) activity, which correlates with a relaxation of the ANS.  In some cases, positive changes 
were documented in EEG, HRV, and psychological effect (Russoniello et al., 2009; Casual 
Games Association, 2007).   
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Purpose of the Study 
 The purpose of this study was to examine the effectiveness of CVGs in reducing 
symptoms of anxiety in a depressed population.  This study utilized an experimental design 
using CVG play as a prescribed activity in comparison to a no-treatment control group.  The 
intent of this research was to test if individuals who play CVGs as a prescribed intervention 
exhibited a decrease in reported symptoms of anxiety on the State-Trait Anxiety Inventory 
(STAI).  To date this type of research has not previously been examined.  If determined that 
prescribed CVG play is an effective treatment for symptoms of anxiety, then persons with 
anxiety will have a tested alternative form of treatment. 
Statement of the Problem 
Current healthcare treatment options and research is limited for persons with anxiety 
(Barlow, 2004).  Healthcare systems currently need methods and interventions that offer relief 
from anxiety symptoms while improving healthcare outcomes (Kasper et al., 2003).  If anxiety 
is left untreated and allowed to build it can negatively impact an individual’s ability to function 
in society and cope with everyday life.  Recent research with non-diagnosed anxious 
participants indicated that CVGs can elicit enhanced mood and decreased stress (Russoniello, 
O'Brien, & Parks, 2009).  By utilizing CVGs as a prescribed activity it is hypothesized that 
individuals with anxiety who play CVGs will have a decrease in symptom severity and issues 
caused by anxiety. 
Objectives 
1. To determine if CVGs are efficacious in reducing state anxiety symptoms in a depressed 
population. 




Ho1:  There will be no significant difference in state anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Ha1:  There will be a positive significant difference in state anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Ho2:  There will be no significant difference in trait anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Ha2:  There will be a positive significant difference in trait anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Limitations 
 When conducting research it is necessary to control for extraneous variables that may 
have an influence on results.  First, one limitation is this study was underwritten by PopCap 
games, whose games were utilized in this study.  Additionally, a technological barrier may be 
experienced between participants who have none or little experience working with computers.  
Other limitations are associated with the measurement of physiological data, which is an estimate 
and necessary precautions must be taken to ensure that the most accurate signal is recorded.  
Additional limitations include morbidity, random recruitment and selection, use of volunteers as 
subjects, inducement, truth in reporting on psychological assessments, and reporting of time 
spent playing CVG at home.  Also, literature does not suggest a specific amount of time needed 
for such an intervention to ensure an effect; thus, it is not known if the treatment protocol 
employed will positively affect individuals with anxiety.  
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Delimitations 
The study findings were delimited to 59 participants from Eastern North Carolina who 
had a score of greater than or equal to 5 on the Patient Health Questionnaire-9 (PHQ-9). 
Assumptions 
 The researcher assumed that participants had answered all questions and required 
documents honestly. The researcher also assumed that participants completed all 
self-administered questionnaires and log sheets as accurately as possible. 
Definition of Terms 
Autonomic nervous system (ANS) - The section of the nervous system responsible for regulation 
of internal organs.  The ANS can be divided into sympathetic and parasympathetic systems 
(Friedman & Thayer, 1998). 
Behavioral state - The behavior exhibited by an individual is dependent upon the information 
obtained or learned (Butcher et al., 2007). 
Casual Video Games (CVGs) – Games that are fun, fast to access, simple to learn, and require no 
previous video game skills or regular time commitment to play.  CVGs are played in small time 
increments due to the fact they are easy to pause, stop, and restart at any time (Casual Games 
Association, 2007). 
Cognition - “Mental processes, including perception, memory, and reasoning, by which one 
acquires knowledge, solves problems, and makes plans” (Butcher et al., 2007, p. G-5). 
Coping mechanism - A technique used to help overcome a problem or disability without 
correcting or removing the core condition (Butcher et al., 2007). 
Electroencephalography (EEG) - By placing electrodes on the scalp of a person at designated 
spots, electrical activity from the brain can be picked up and different waves and amplitudes can 
be measured (Peper, Tylova, Gibney, Harvey, & Combatalade, 2008). 
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Heart Rate Variability (HRV) - A physiological measure that is directly related to the balance of 
the autonomic nervous system, which is in control of the body.  HRV reflects the sympathetic 
(anxiety) or parasympathetic (relaxation) initiation within the body (Friedman & Thayer, 1998). 
Patient Health Questionnaire (PHQ) – A self-administered screening and diagnostic tool that 
uses diagnostic criteria from the Diagnostic and Statistical Manual of Mental Disorders, 4th 
Edition, Text Revision (2000) (DSM-IV-TR) to identify specific disorders and measure symptom 
severity (Spitzer et al., 1994). 
Profile of Mood States (POMS) – A self-administered psychological inventory that measures six 
subscales: tension, depression, anger, vigor, fatigue, and confusion.  This inventory can be 
utilized to examine both “last week including today” and “right now” instructions (Multi-Health 
Systems Inc., 2003).  
Psychotherapy - “Treatment of mental disorders by psychological methods” (Butcher et al., 
2007, p. G-19). 
Salivary-Alpha Amylase (sAA) - A non-invasive standard measure that allows for repeated 
assessments of variables such as hormones, antibodies, and stress (Mandel, 1980; Mandel, 1990; 
Smith et al., 1991; Tabak, 2001; Rantonen, 2003). 
State-Trait Anxiety Inventory (STAI) – A self-administered inventory that distinguishes between 
the temporary condition “state anxiety” (S-Anxiety) and the more general “trait anxiety” 
(T-Anxiety).  This inventory allows researchers to separate feelings of anxiety and depression 
(Spielberger, Gorusuch, & Lushene, 1970). 
	  CHAPTER II:  LITERATURE REVIEW 
Anxiety 
 Anxiety is a broad sensation of uneasiness that is marked by an inner state of 
apprehension and a belief that one is in some type of danger (Butcher, Mineka, & Hooley, 2007). 
Anxiety and fear are two different emotions but are commonly regarded as the same.  Fear is 
defined by an obvious source of danger.  However, with anxiety, danger is not typically 
specified clearly, as it can occur in situations where danger is not observable (Butcher et al., 
2007; Spielberger, 1985).  Anxiety is often described as a mixture of unsettling sensations and 
thoughts comprised of different components that are directly affected (Butcher et al., 2007).   
While small to medium bouts of anxiety can be helpful in learning and skill acquisition, 
frequent bouts of anxiety that sustain over long periods of time can lead to anxiety disorders.  
Anxiety directly affects the individual’s cognitive/subjective, physiological, and behavioral 
states (Kasper, Boer, & Sitsen, 1994). Within the cognitive/subjective level, anxiety has the 
ability to bring about negative mood, unnecessary worries, fixation on self, and loss of control of 
actual fear.  Physiologically, the body is not in a homoeostatic state (Kasper et al., 1994).  The 
body is in a state of chronic stress and tension, leaving the person prepared for any danger that 
may occur.  Lastly, on the behavioral level, situations or environments where danger could 
occur are frequently avoided (Butcher et al., 2007). 
In a person’s lifetime, threatening experiences will occur and anxiety is learned.  For 
many years, research experiments have been conducted on human and nonhuman animals to 
examine how anxiety and fear are provoked and controlled (Kasper et al., 1994).  This research 
demonstrates that anxiety is learned, and is also conditionable (Butcher et al., 2007).  When a 
normally neutral object becomes constantly paired with stimuli, and negative reactions steadily 
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occur and are predictable, these neutral objects can become paired with the negative stimuli to 
illicit anxiety (Spielberger, 1985; Spielberger et al., 1970). 
Physical symptoms typically associated with anxiety include heart palpitations, 
exhaustion, queasiness, thoracic angina, loss of breath, stomachaches, and headaches (Thayer, 
Friedman, & Borkovec, 1996).  When the body prepares to deal with a threat, blood pressure 
and heart rate increase rapidly.  Blood flows to major muscle groups and the immune and 
digestive systems become subdued.  Sometimes panic attacks are experienced with anxiety.  
Panic attacks can come without notice, and as with anxiety, the accompanying fear is generally 
unreasonable but feels very real. Experiencing a panic attack can seem as if one is dying, going 
crazy, or having a heart attack (Butcher et al., 2007). 
Prevalence 
Anxiety is a prevalent issue among people in America.  Anxiety has no barriers or 
constraints when targeting affected persons.  There are no age limits, gender barriers, or 
environmental constraints.  In a recent survey, it was found that close to 40 million Americans 
(about 18%) will encounter some form of anxiety disorder at least once in their lifetime 
(National Institutes of Mental Health, 2009).  In fact, anxiety disorders are the most commonly 
diagnosed category for psychological disorders found in women, and rank second in 
psychological disorders for men (Kessler et al., 1994).  Even more startling are the findings 
from Kessler et al. (1994), who found that within a 12-month period, approximately 23 percent 
of women and 12 percent of men experienced at least one anxiety disorder. 
With more than 40 million adults suffering from an anxiety disorder, healthcare systems 
are shifting to increase the quality of care and cost effectiveness of treatment (Kessler et al., 
2005).  The recent healthcare shift includes five key components, all of which are focused 
towards increased health outcomes, decreased costs, and increased effectiveness of treatment 
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(Royston, 1998).  Anxiety has produced enormous personal, economic, and healthcare 
problems for those involved.  Kessler and Greenberg (2002) found that spending on anxiety 
disorders in the United States is more than $100 billion in indirect and direct costs annually. 
History of Treatments 
Throughout history there have been several effective therapies to help relieve anxiety 
such as medication, psychotherapy, biofeedback, virtual reality, and eye movement 
desensitization and reprocessing (EMDR).  As the medical world continues to explore different 
areas of research, new treatments for anxiety are unveiled.  Generally, individuals diagnosed 
with anxiety are prescribed medication, psychotherapy, or a combination of the two therapies.  
Before being prescribed treatment patients are assessed on specific symptoms and problems 
associated with anxiety.  Anxiety is often comorbid with other psychological disorders or 
conditions, and it is important to understand to what extent anxiety is the cause or caused by 
related comorbid conditions (National Institutes of Mental Health, 2009). 
Persons experiencing anxiety sometimes must engage in several different treatments 
before they are able to find relief.  When reevaluating a patient it is important the doctor know 
what previous treatments were tried, the duration, dosage amount, and side effects, etc..  When 
a treatment does not work it can make the patient feel as if he or she has failed and exacerbate his 
or her anxiety.  The truth more likely is linked to poorly performed or incorrect treatment, or 
treatment that is not effective given specific personal characteristics of the individual (National 
Institutes of Mental Health, 2009).  Some examples of anxiety treatments used today include 
medications, psychotherapy, electromyography (EMG), virtual reality, and EMDR (National 
Institutes of Mental Health, 2009; Coelho, Waters, Hine, & Wallis, 2009; Hiebert & 
Fitzsimmons, 1981; Shapiro, 1999). 
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A common misconception about medication for patients with anxiety is that medication 
alone is the cure (National Institutes of Mental Health, 2009).  However, medication is 
prescribed to help with the process of psychotherapy.  The main types of medications used are 
anti-depressants and anti-anxiety drugs.  Antidepressants, which were created for patients with 
depression, are also effective with relieving anxiety symptoms.  These medications tend to take 
4 to 6 weeks to start relieving symptoms but begin changing brain chemistry after the first dose 
(National Institutes of Mental Health, 2009; Butcher et al., 2007). 
Selective serotonin reuptake inhibitors (SSRIs) are one of the newer antidepressants 
prescribed for anxiety.  These SSRIs work by manipulating levels of serotonin, a 
neurotransmitter in the brain that allows cells within the brain to communicate with one another.  
Upon starting the medication, SSRIs can occasionally produce side effects such as nausea, jitters, 
or sexual dysfunction.  Like other medications, dosage must be adjusted throughout usage or 
may require changing to another SSRI.  Examples of these medications include Prozac, Zoloft, 
Lexapro, and Paxil (National Institutes of Mental Health, 2009; Butcher et al., 2007). 
Older antidepressants include Tricyclic’s and monoamine oxidase inhibitors (MAOIs).  
Tricyclics are just as effective as SSRIs but tend to have additional side effects such as vertigo, 
lethargy, dry mouth, and weight gain.  These MAOIs are the oldest form of anti-depressant 
medication and appear to be the most dangerous (Thase, Trivedi, & Rush, 1995).  When taking 
MAOIs specific foods and drinks must be taken out of one’s diet.  Certain medications are not 
allowed to be taken, for example some birth control pills, pain relievers, cold medication, and 
herbal supplements.  If mixed together unhealthy increases in blood pressure can take place or 
if taken along with SSRIs, a condition called “serotonin syndrome” can happen.  Side effects 
include confusion, delusions, sweating, muscle rigidity, convulsions, and other life threatening 
conditions (National Institutes of Mental Health, 2009). 
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Anti-anxiety drugs are high-potency benzodiazepines that are typically used for short 
periods of time.  Other than making the individual drowsy, the drugs tend to have few side 
effects when used properly.  Some negative problems include one must constantly increase 
dosage to maintain a continuous effect.  Anti-anxiety drugs can become very addicting for 
persons’ who have previously had substance abuse problems (Busto, Romach, & Sellers, 1996).  
If medication is stopped suddenly without weaning anxiety symptoms can return almost 
immediately.  Problems like this have kept some physicians from prescribing these pills unless 
other options have been exhausted (National Institutes of Mental Health, 2009; Butcher et al., 
2007). 
Psychotherapy is a common form of treatment used for anxiety and is conducted by a 
mental health specialist who can identify and treat symptoms of anxiety.  The most common 
form of psychotherapy is cognitive-behavioral therapy (CBT).  Cognitive-behavioral therapy 
has been found to be very useful allowing thought processes to be evaluated and changed to no 
longer support negative thoughts or fears.  Cognitive-behavioral therapy is also used to deal 
with behavior towards situations that may be anxiety provoking and is usually provided for a 12 
week duration period in individual or group sessions.  During therapy, weekly assignments are 
designated for completion between meetings.  Evidence points to CBT having longer lasting 
results than medications and it can be utilized repeatedly if needed.  On the other hand, some 
negative aspects associated with CBT include multiple treatment visits that can last weeks or 
months, insurance can deny treatment, the cost to the patient, and the intense emotional effort 
required from the client (National Institutes of Mental Health, 2009; Butcher et al., 2007; 
Neukrug, 2007). 
Biofeedback utilizing electromyography (EMG) for the treatment of anxiety was 
compared to established clinical procedures (Hiebert & Fitzsimmons, 1981).  Hiebert and 
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Fitzsimmons (1981) research design included a two-stage, four-group, repeated-measures design 
with a nonorthognonal control group.  The four treatment groups were (1) EMG biofeedback 
training, (2) cognitive monitoring, (3) EMG biofeedback training and cognitive monitoring, (4) 
high expectancy discussion groups, and (5) waiting list control.  Each treatment group (groups 
1-4) participated in six 50-minute sessions, while waiting list control subjects (group 5) were told 
in order to begin treatment researchers would need to obtain an established anxiety level.  
Participants (n= 173) were recruited from announcements in the local media and large 
undergraduate classes.  The Institute for Personality and Ability Testing Self-Analysis Form 
(IPAT) was used to measure the individual’s current perception of their anxiety level.  
Additionally, a 5-minute frontal EMG baseline was collected at the beginning of each session.  
Both measures were administered throughout all treatment groups at the start of session 1, again 
at the start of session 3, and again during session 6.  Three procedures were examined in this 
study: cognitive self-monitoring, systematic desensitization, and biofeedback using EMG.  A 
significant (p ≤ .05) decrease in IPAT scores and significant (p ≤ .05) EMG changes were 
demonstrated within the EMG biofeedback-training group.  
Coelho et al. (2009) reviewed the use and benefits of treating patients with anxiety 
utilizing virtual reality.  The purpose of this study was to examine virtual reality treatments, 
ranging from traditional exposure therapies to more recent virtually guided ones, utilized with 
patients suffering from anxiety.  Currently, virtual reality exposure therapy (VRET) is one of 
the leading virtual reality protocols being used to treat patient with anxiety (Coelho et al., 2009).  
Virtual reality exposure therapy produces the same fears and physical symptoms that would 
occur if placed in a similar situation.  Patients wear headgear that connects to a computer 
monitor, immersing the patient into a virtual world displaying the anxiety-provoking 
environment.  This type of treatment allows participants to interact in an environment that is 
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safer than the real world, allowing fears to be faced in a controlled environment.  Other benefits 
to this approach are related to eliminating logistical, financial, and personal concerns related to 
treatment.  Virtual reality exposure therapy offers easy access, as there is no need to leave the 
office when compared to other exposure treatments.  One benefit VRET offers is it protects 
patients’ fears from a confidentiality breach as it can be performed in a private setting.  Virtual 
reality exposure therapy patients also express a preference for this form of therapy over exposure 
therapy.  Through VRET, patients can be exposed to anxiety triggers in a safe way, where this 
was not possible in the past (Coelho et al. 2009).  Krijn, Emmelkamp, Olafsson, and Biemond 
(2004) performed a review of literature on research surrounding the use of VRET with anxiety 
disorders.  Research indicated there are studies demonstrating VRET to be more effective than 
no-treatment for specific anxiety disorders and in conjunction with other therapies.  It is noted 
that there is a lack of the controlled and randomized studies needed to demonstrate VRETs 
effectiveness as a stand-alone treatment (Krijn, Emmelkamp, & Biemond, 2004). 
Shapiro (1999) reviewed four controlled studies of EMDR, which stated that 84 to 100% 
of their subjects who were diagnosed pre-treatment as suffering from an anxiety disorder such as 
posttraumatic stress disorder, no longer retained their diagnosis post-treatment.  Shapiro (1999) 
examined the fidelity and validity of these four studies, as well as, described which procedures 
and protocols may have the greatest effect on treatment outcomes.  The four controlled studies 
examining the effectiveness of EMDR were conducted by independent research teams, which 
involved a total of 107 subjects. Each study required participants to participate in a treatment 
program consisting of 7 to 10 treatment sessions and daily homework.  To maximize effect, 
EMDR combined different psychotherapies into one structured treatment, which included 
psychodynamic, cognitive behavioral, interpersonal, experiential, and body-centered therapies 
(Shapiro, 1999).  Eye movement desensitization and reprocessing in these studies were a 
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combined eight-phase treatment protocol, which are standardized protocols and procedures that 
should be utilized in clinical and research settings.  Overall, the study indicated that when 
EMDR is applied correctly it can significantly decrease symptom severity of and, in some cases, 
patients no longer retained their diagnosis (Shapiro, 1999).  
Anxiety Measurement 
This research was part of a larger study that included multiple measures.  The following 
instruments were used and are considered valid and reliable measures of anxiety and other mood 
states: State-Trait Anxiety Inventory (STAI), Profile of Mood States (POMS), PRIME-MD 
Patient Health Questionnaire (PHQ), electroencephalography (EEG), hearth rate variability 
(HRV), and salivary alpha amylase (sAA).  However, while all of these instruments are 
included in the literature review only the STAI was used to test the hypotheses. 
According to Spielberger (1983), state (S-Anxiety) anxiety refers to a transitory 
emotional state or condition that can be characterized by subjective, consciously apparent 
feelings of tension and apprehension, and arousal of the autonomic nervous system.  On the 
contrary, trait (T-Anxiety) anxiety refers to an individual’s proneness for anxiety and a common 
tendency to respond with anxiety when confronted with a perceived threat.  
The STAI is a brief, self-report inventory that consists of 20 S-Anxiety questions and 20 
T-Anxiety questions, for a total of 40 anxiety questions.  Both scales can be administered to 
subjects independently of each other or combined.  S-Anxiety questions focus on how the 
person feels right now, at that moment.  Participants are able to rate their current S-Anxiety on 
the following 4-point intensity scale: (1) Not at all; (2) Somewhat; (3) Moderately so; and (4) 
Very much so (Spielberger, 1985).  T-Anxiety questions ask the person to score how they 
normally feel by rating themselves on the following 4-point frequency scale: (1) Almost never; 
(2) Sometimes; (3) Often; and (4) Almost always (Spielberger, 1985).  The STAI takes 
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approximately 5 to 10 minutes to complete.  Concurrent validity of the T-Anxiety scale was 
demonstrated through correlations with the Taylor Manifest Anxiety Scale (TMAS) and the 
Anxiety Scale Questionnaire (ASQ).  Correlations with neuropsychiatric patients and college 
students ranged from .70 to .85 (Spielberger, 1985).  Construct validity for the S-Anxiety scale 
was demonstrated through research studies where the inventory was administered during high- 
and low-stress conditions (Spielberger, Gorusuch, & Lushene, 1970).  For example, students 
who were preparing for a test or viewing a stressful movie scored significantly higher than those 
returning from a 10-minute relaxation session. 
Since 1971, POMS has demonstrated efficacy as an inventory that measures six 
individual moods including anxiety.  The POMS inventory can be administered and scored 
using “Last Week” and “Right Now” instructions.  For patients, POMS are quickly and 
precisely completed and simple to comprehend.  The POMS database is based from psychiatric 
outpatients, college students, adults, and geriatric norms.  Respondents use self-report 
inventories to rate each question.  Each item is rated on a 5-point scale varying from “not at all” 
to “extremely”.  Construct and predictive validity has been demonstrated through numerous 
research studies.  A high level of internal consistency (.90 or above) and a reasonable level of 
test-retest reliability (.68-.74) have been exhibited through other studies and all factors 
(Multi-Health Systems Inc., 2003; Watson et al., 1995). 
The PHQ has been updated from the original PRIME-MD, to a more user-friendly 
assessment.  What was the original two-part questionnaire is now a solo, three-page survey that 
the patient completes.  After completing the test, the clinician applies diagnostic algorithms 
located at the bottom of the page.  From this the diagnoses and symptoms can be recorded and 
monitored (Spitzer, Kroenke, & Williams, 1999).  The PHQ offers quick and accurate analysis 
of the most common mental disorders currently within primary care.  The PHQ is equipped 
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with the tools needed for the busy clinician and the primary care researcher.  Also, items 
utilized in the PHQ are derived from the American Psychiatric Associations Diagnostic and 
Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) (Spitzer et al., 
1994). 
When comparing operating characteristics of the PHQ and the original PRIME-MD, 
results indicate a satisfactory relationship with the previous results obtained.  Notable increases 
in the sensitivity of the PHQ were demonstrated in major depressive disorder (57% to 73%), 
panic disorder (57% to 81%), and eating disorders (73% to 89%) (Spitzer et al., 1999; Spitzer et 
al., 1994).  Other sensitivity percentages are satisfactory; any PRIME-MD psychiatric diagnosis 
(75%), any mood disorder (61%), any anxiety disorder (63%), and probable alcohol 
abuse/dependence (62%) (Spitzer et al., 1999).  Specificity percentages in six of the eight 
categories were greater than or equal to 96% with the exception of two categories, any 
PRIME-MD psychiatric diagnosis (90%) and any mood disorder (94%) (Spitzer et al., 1999).  
The PRIME-MD has been demonstrated to be a valid instrument (Spitzer et al., 1999).  
Changes in brain activity were recorded using a 10-channel EEG device (NEXUS-10).  
Electroencephalography symmetry has been used over time to test the effects of stimuli on the 
brain and it is now typically recognized that hypo-activity in the left hemisphere of the brain is 
interconnected with stress and negative affect (Field, Grizzle, Scafidi, & Schanberg, 1996).  
Several therapies, including massage, have been demonstrated to help people increase brain 
activity areas associated with anxiety and stress to areas associated with relaxation and alertness 
(Fox, 1991; Field et al., 1996).  
Heart rate variability and recent research surrounding its uses has indicated it to be a 
valid measure in viewing the relationship between anxiety and autonomic nervous system (ANS) 
activity (Friedman & Thayer 1998).  Heart rate variability data can be collected using a blood 
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volume pulse (BVP) sensor, photoplethysmography (PPG) pulse wave sensor, or a wrist-to-wrist 
electrocardiograph (ECG) device.  Heart rate variability is a standardized physiological 
measurement that directly reflects one’s ANS regulation.  More specifically, HRV breaks the 
ANS down to smaller levels including the Sympathetic Nervous System (SNS) (stress, anxiety) 
and Parasympathetic Nervous System (PNS) (relaxation, calmness).  Cannon’s (1929) model 
noted that the hypothalamus was consistently activated when experiencing fear or anxiety, which 
leads to frequent activations of the SNS response.  Heart rate variability changes indicated by 
increases in high frequency (PNS) and low frequency (SNS) norms and low/high frequency 
ratios are used as specific indicators of stress and mood (Wilkinson, 1998; Davidson, 1988). 
The use of sAA as a diagnostic tool and for measurement has become increasingly 
popular across multiple healthcare fields including physiology, dentistry, and internal medicine 
(Mandel, 1993; Rantonen, 2003).  This non-invasive standard allows for repeated measures of 
variables such as hormones, antibodies, and stress (Mandel, 1980; Mandel, 1990; Smith et al., 
1991; Tabak, 2001; Rantonen, 2003).  By measuring saliva’s flow rate, viscosity, proteins, and 
amylase specific changes in the ANS can be detected.  Salivary alpha amylase has 
demonstrated in previous studies that as SNS activity increases so does secretion and as PNS 
activity increases so does flow rate (Yamaguchi et al, 2003).  During both physical and 
psychological stress, increases in sAA have been recorded (Yamaguchi et al, 2003).   
Casual Video Games 
The Casual Games Association (2007) defines CVGs as fun, easily accessible, fast to 
learn, requiring no prior gaming experience, knowledge, or required time commitment to play. 
Most CVGs are based from previous game concepts from arcades or Atari.  Also, CVGs tend to 
be easy to pause, stop, and restart, while preventing loss of fun (Casual Games Association, 
2007). 
	  18 
According to Casual Games Association (2007) there are 200 million people playing 
Casual Video Games (CVGs) online each month.  In fact, Microsoft Solitaire for Windows XP 
is opened more than any other casual video game (Casual Games Association, 2007).  With 
increased use and interest, research has begun to investigate benefits of such games. 
Recently, the Casual Games Association (2007) released a statement that CVGs are 
attracting the interest of more people.  The term “gamer” typically brings about the 
stereotypical image of a teenager who enjoys video games.  However, research is proving this 
wrong, indicating that an increasing number of young and old people are playing CVGs.  The 
nature of CVGs is simple and easy, which tends to increase interest from people who normally 
would not be interested.  Casual video gamers range in culture, age, and lifestyle.  Casual 
video games allow for people to access games while at work, school, home, or even on the road.  
The CVG consumer base has expanded rapidly due to the ease and availability of play.  Many 
people report playing CVGs for quite a few reasons.  Some reasons include cognitive exercise, 
fun, and relaxing (Casual Games Association, 2007). 
Casual Video Games are played on various gaming platforms.  These platforms include 
PCs, online networks, handheld gaming devices, and mobile phones (Russoniello et al., 2009).  
Casual Video Games have produced massive increases in popularity throughout online 
communities, which is viewed as a major strength.  With smart phones reaching over 1.15 
billion sales in 2007 it has made CVGs more accessible and available for play (Gartner Research, 
2008). 
Research around video games and their effects on players has been concentrated on 
negative effects such as violent behaviors and aggression.  These studies tend to portray games 
as tools for turning people into hyper aroused-aggressive bullies (Calvert & Richards, 2006). 
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Anderson and Bushman (2001) performed a meta-analytic review of the video-game 
research literature to examine if violent video games exacerbate aggressive behaviors in both 
children and young adults.  The purpose of the study was to examine the effects violent video 
games had on aggressive behavior, prosocial behavior, aggressive cognition, aggressive affect, 
and physiological arousal.  The literature search retrieved 35 research reports and 54 
independent samples of participants for a total of 4,262 participants.  Studies were only 
reviewed if they examined effects of playing violent video games.  However, studies where 
subjects watched others play violent video games were excluded.  Results indicated that high 
video game violence was significantly related with increased aggressive behavior, decline in 
prosocial behavior, rise in aggressive thought, increase in aggressive affect, increase in 
physiological arousal, and that even short-term exposure to violent video games can lead to brief 
increases in aggression. 
Anderson and Dill (2000) performed a study that examined the effects of video game 
violence.  The purpose of the study was to start building an empirical foundation to better 
understand the effects of video game violence.  Participants involved in the study included 272 
undergraduates from a large Midwestern university.  Participants completed a self-report 
questionnaire, which collected data on aggressive behavior and delinquency.  Assessments 
utilized within the self-report questionnaire include: Caprara Irritability Scale (CIS), Buss-Perry 
Aggression Questionnaire (AQ), and Delinquency Scale.  Results from the study indicated that 
video game violence is significantly related (p ≤ .05) to aggressive behavior and delinquency. 
There are only a few studies completed that have looked at health related outcomes or 
positive effects of video gaming.  With increased interest researchers are beginning to research 
the human-computer interaction that takes place when playing a game.  They want to 
understand how it works, what it does, and what possibilities could be exposed (Barr, Noble, & 
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Biddle, 2007).  Other research has examined positive effects such as cognition, therapeutic 
adaptability, relationships, and educational benefits (Gelfond & Salonius-Pasternak, 2005).   
Durkin and Barber (2002) performed a study that examined if computer game play has a 
negative impact on young people.  The purpose of the study was to examine the relationship 
between the amount of computer game play and measures of adjustment or risk taking.  The 
data used in this study came from Wave 5 of the Michigan Study of Adolescent Life Transitions 
(MSALT).  Data utilized from the Wave 5 was collected from 1,304 participants that were in 
the 10th grade and 16 years of age.  Questionnaires were utilized to examine computer game 
use, adjustment, self-concept, risk behaviors, and social context.  Results from the study 
indicated that the low computer use group reported their depressed mood to be significantly (p ≤ 
.05) lower when compared to the high and no use computer groups. 
Russoniello et al. (2009) was one of the first research studies to target health outcomes 
from CVGs.  The purpose of the study was to examine whether CVGs are an effective 
intervention in reducing mood, anxiety, and stress in a “normal” population.  Participants 
included in the study were 143 subjects from Eastern North Carolina with a mean age of 26.  
Participants completed a self-report questionnaire, Profile of Mood States (POMS), and 
physiological measurements were used to examine the effectiveness of CVGs in reducing mood 
and stress.  Physiological parameters utilized included electroencephalography (EEG) and heart 
rate variability (HRV).  Results indicated that the CVGs significantly (p ≤ .05) increased mood 
when compared to the baseline measurement.  Changes in physiological parameters were 
congruent with the questionnaire measures demonstrating an increase in mood and a decrease in 
stress and anxiety. 
In the current US population approximately 18.1 percent of the adult population is 
diagnosed with an anxiety disorder (National Institute of Mental Health, 2010b).  There is a 
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need for preventative interventions that are both health and cost effective.  CVGs cost less than 
prescription medications and do not possess side effects typically associated with anxiety 
medications.  
This study examined the potential of CVGs as an alternative or adjunct to medications for 
treatment of anxiety.  Through the present study, it is hoped to increase ideas that CVGs could 
eventually be utilized as a prescriptive medical therapy-demonstrating efficacy through 
psychological and physiological measures. 
	  CHAPTER III:  METHODS 
Introduction 
 
The purpose of this study was to examine the effectiveness of CVGs in reducing 
symptoms of anxiety.  This study utilized a randomized controlled experimental design with 
individuals who utilized CVGs as a prescribed intervention in comparison to a no-treatment 
control group.  The intent of this research was to examine whether individuals who play CVGs 
as a prescribed intervention will have a decrease in reported symptoms of anxiety on the 
State-Trait Anxiety Inventory (STAI).  To date, research examining the use of CVGs as a 
prescribed intervention and the effect it has on severity of anxiety symptoms over time has not 
been examined.  If determined that prescribed CVG play is an effective treatment of symptoms 
of anxiety, then persons with anxiety will have a potential alternative form of treatment. 
Study Design 
 East Carolina University's Psychophysiology Lab and Biofeedback Clinic completed a 
recent study that demonstrated individuals, “normal participants”, who played CVGs improved 
their mood and symptoms of undiagnosed depression (Russoniello et al., 2009).  These findings 
along with subjective evidence has led researchers to hypothesize that CVGs could have the 
potential to help persons with anxiety to better cope with symptoms of anxiety (Russoniello et 
al., 2009).  The method used involves a randomization of participants into control and 
experimental groups, where a comparison of physiological, biochemical, and psychological 
variables will be done.  Participants randomized into the experimental group were given a 
choice of three popular CVGs to play.  Research has demonstrated that freedom to choose is an 
important precursor to experiencing the full benefits of recreation participation.  The participant 
then played the games of their choice for 30 minutes while their physiology was recorded.  In 
addition to the two lab sessions scheduled one month apart, the experimental group was 
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instructed to play the CVG of their choice at home for at least 30 minutes three times per week 
for one month.  Additionally, participants were asked to keep a log of the amount of time spent 
playing the game during the month.  Participants randomized into the control group engaged in 
a web-based review of the National Institutes of Mental Health consumer web site on depression 
for 30 minutes.  This method was used to simulate the experimental conditions as closely as 
possible.  During the one-month period between sessions control group participants were told to 
refrain from any CVG play.  
Population 
Participants included 59 individuals from Eastern North Carolina.  Of the 59 
participants who completed the study, 30 were randomly assigned to the experimental group and 
29 were randomly assigned to the control group.  Participants were required to be at least 18 
years of age, able to read and speak English, and have a score greater than or equal to 5 on the 
Brief Patient Health Questionnaire (PHQ-9).  This criterion was used to ensure that individuals 
included in the study were adults experiencing at least minimal symptoms of depression based 
from the American Psychiatric Associations Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition, Text Revision (DSM-IV-TR) criteria standards.  Non-qualifying 
volunteers were given a CVG of their choice. 
Sample and Sampling Procedures 
Recruitment for the study began after approval from the University and Medical Center 
Institutional Review Board (UMCIRB) of East Carolina University (ECU).  The study’s 
hypotheses, methodology, and logistical plan were developed between July 2009 and August 
2010.  Likewise, the clinical state of the study was conducted between July 2010 and November 
2010.  Recruitment was completed by word of mouth and distributing a recruitment flier to 
possible referral sources, i.e. local mental health agencies, family medicine practitioners, and 
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local newspapers.  The flier was also posted at various campus locations, i.e. ECU, Pitt 
Community College Campus Counseling Centers, ECU Student Recreation Center, etc..  A 
statistical Random Number Generator was used to randomize participants into experimental and 
control groups, which was completed prior to the start of the study. 
Site/Setting 
 This study took take place at East Carolina University’s, Carol G. Belk Building located 
in Greenville, North Carolina.  When working with a clinical population, such as persons with 
depression, confidentiality is of great importance to the participant and researcher.  To ensure 
that participants’ identities were kept confidential, the Sensory Motor Room located across the 
hall from the East Carolina University's Psychophysiology Lab and Biofeedback Clinic was 
utilized.  The Sensory Motor Room was arranged so that the participant and researcher were 
located on the far side of the room facing the outside wall.  Both were seated next to each other 
during each session.  The researcher sat on the right side of the table with a computer that was 
connected to physiological equipment, which recorded EEG and HRV data.  This allowed the 
researcher to make sure that the physiological data being collected was clean.  To the left of the 
researcher sat the participant.  The participant also had a computer located directly in front of 
them, on which they would play their CVG of choice or would read the National Institutes of 
Mental Health’s website on depression.  The Sensory Motor Room remained locked during 
each session.  The researcher remained in the Sensory Motor Room with the participant for the 
entire length of each session, except to take saliva samples that were collected to the freezer.  
These precautions were taken to help minimize the potential for participants to be identified and 




Data Collection Procedures 
Table 1 presents an overview of the data collection process.  During the initial meeting, 
the researcher screened participants for entrance into the study and explained the purpose of the 
study including requirements of the program and data collection procedures.  The researcher 
remained in the room to monitor all physiological signals for integrity, as well as, to answer any 
questions regarding inventories being answered.  After completion of the informed consent, 
participants were asked to fill out pre-intervention questionnaires including the Brief Patient 












PHQ, STAI, POMS,HRV, 
EEG, sAA 





3x per week for 
30 minutes, 12 
sessions  
Participant log playing time 6 hours 




PHQ, STAI, POMS, HRV, 
EEG, sAA 
1 hour 30 
minutes 
Total Time Hours 
Control =3 hours 
Experimental =9 
hours 
Table Key: PHQ-9 (Patient Health Questionnaire-9); PHQ (Patient Health 
Questionnaire); STAI (State-Trait Anxiety Inventory); POMS (Profile of 
Mood States); EEG (Electroencephalography); Heart Rate Variability 
(HRV); Salivary Alpha Amylase (sAA) 
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The STAI was used to measure changes in state and trait anxiety.  The POMS and PHQ 
were also used to assess anxiety and other aspects of mood.  Participants also completed a 
demographic profile (Appendix D) regarding information about age, gender, ethnic background, 
and previous game play.  Participants were connected to the Nexus 10, physiological 
monitoring equipment, in order to measure changes in brain activity using EEG as well as ANS 
change using HRV.  To do so a software computer screen was developed that automatically 
collected 6 minutes of baseline and 30 minutes of intervention providing normative data and R/L 
brain alpha ratio scores.  After completion of all required forms and all physiological equipment 
was connected, participants were asked to fill up a tube with saliva for measurement of sAA.  
Participants were given a tube with a straw, in which they spit through the straw into the tube 
until it was filled up to the appropriate mark.  Upon completion of baseline assessments, the 
individual then opened an envelope to reveal whether they were randomized into the 
experimental or control group.  After completion of the intervention the same pre-intervention 
measures, PHQ, STAI, and POMS, were completed once again by both the experimental and 
control group.  To further protect the individual’s identity, all forms were coded and kept in 
separate folders. 
During the next four weeks, control subjects were asked to refrain from any CVG play.  
However, the experimental group was asked to record each CVG session they played.  On a log 
sheet (Appendix H), participants recorded the date and duration of each CVG session.  After 
four weeks were completed, experimental and control group participants returned to meet with 
the researcher.  Participants were then asked to fill out the same pre-intervention questionnaires 
and give saliva samples, as during the initial session.  Participants were then connected to EEG 
and HRV physiological monitoring equipment, where a software computer screen was developed 
that automatically collected 6 minutes of baseline and 30 minutes of intervention providing 
	  27 
normative data and R/L brain alpha ratio scores.  Post-intervention, participants again filled out 
the PHQ, STAI, POMS, and gave a saliva sample.  Upon successfully completing the study, 
participants received three free CVGs and a $100 gift card for their participation, which was 
funded by PopCap games. 
Treatment Protocol 
 Participants in the experimental group were prescribed a CVG of their choice to play with 
instructions regarding frequency and duration.  During the first session participants played a 
CVG of their choice for 30 minutes, while having physiological data collected.  Over the next 
four weeks participants were required to play their chosen CVG for a minimum of 30 minutes 
per session.  The participant also needed to play the CVG a minimum of three times each week 
over a one-month period.  Participants could play more than the minimum amount of game play 
required if they wished but were asked to document any extra time.  At the end of the four 
weeks participants needed to have completed a minimum of 12 sessions playing their CVG. 
Hypotheses 
Ho1:  There will be no significant difference in state anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Ha1:  There will be a positive significant difference in state anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Ho2:  There will be no significant difference in trait anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Ha2:  There will be a positive significant difference in trait anxiety symptom severity scores as 





This research was part of a larger study that included multiple instruments, including the 
Patient Health Questionnaire (PHQ), State-Trait Anxiety Inventory (STAI), and Profile of Mood 
States (POMS) that were administered pre and post implementation for both groups.  Baseline 
electroencephalography (EEG) and heart rate variability (HRV) physiological data was collected.  
Also, a salivary alpha amylase (sAA) sample was gathered pre and post intervention.  To 
collect demographic information a demographic profile was administered during the initial 
session along with the other health questionnaires.  It is recognized that this research was part 
of a larger study and only the STAI was used to test hypotheses.  However, all instruments 
utilized in the larger study were included to demonstrate the methodology of the larger study. 
Patient Health Questionnaire (PHQ) 
The PHQ is based on an earlier edition of the Primary Care Evaluation of Mental 
Disorders (PRIME-MD).  The PRIME-MD was the first assessment to use the Diagnostic and 
Statistical Manual of Mental Disorders, Revised Third Edition (DSM-III-R) diagnostic criteria to 
actually identify specific disorders (Spitzer et al., 1994).  Likewise, items utilized in the PHQ 
are derived from the American Psychiatric Associations Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) (Spitzer et al., 1994).  In this study 
the depression screener (PHQ-9) located on the front page was used as a screening tool for 
admission into the study and if the individual qualified the remaining sections of the 
questionnaire were completed.  After completing the test, the researcher applied diagnostic 
algorithms located at the bottom of the page.  From this the diagnoses and symptoms can be 
recorded and monitored (Spitzer, Kroenke, & Williams, 1999).  The PHQ was administered 
pre-assessment both sessions in this study and participants were instructed to answer questions 
based on the previous two and four weeks, dependent upon the section being completed.  
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During the post assessment both sessions, participants were instructed to answer questions as to 
how they felt at that moment. 
State-Trait Anxiety Inventory (STAI) 
To determine if there was any change in participants anxiety level the STAI was used to 
measure changes in both state (S-Anxiety) and trait (T-Anxiety) anxiety.  The STAI is a brief, 
self-report inventory that consists of 20 S-Anxiety questions and 20 T-Anxiety questions, for a 
total of 40 anxiety questions.  S-Anxiety questions focused on how you feel right now, at that 
moment.  Participants were able to rate their current S-Anxiety on the following 4-point 
intensity scale: (1) Not at all; (2) Somewhat; (3) Moderately so; (4) Very much so.  T-Anxiety 
questions asked participants to score how they normally feel by rating themselves on the 
following 4-point frequency scale: (1) Almost never; (2) Sometimes; (3) Often; (4) Almost 
always.  The S-Anxiety scale was administered pre and post session 1 and session 2 and the 
T-Anxiety scale was administered pre session 1 and pre session 2. 
Profile Of Mood States (POMS) 
The POMS has demonstrated efficacy as an inventory that measures the following six 
subscales: tension (anxiety), depression, anger, vigor, fatigue, and confusion.  The POMS 
database is derived from psychiatric outpatients, college students, adults, and geriatric norms.  
Respondents used self-report inventories to rate each question.  Each item was rated on a 
5-point scale varying from “not at all” to “extremely” (Multi-Health Systems Inc., 2003).  .  
The POMS inventory was administered and scored using “Last Week” directions for pre session 
1 and pre session 2 and “Right Now” instructions for post session 1 and post session 2.  
Electroencephalography (EEG) 
Changes in brain activity was recorded using a 10-channel electroencephalography 
device (NEXUS-10).  Electroencephalography symmetry has been used over time to test the 
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effects of stimuli on the brain and it is now typically recognized that hypo-activity in the left 
hemisphere of the brain is interconnected with stress and negative affect (Field, Grizzle, Scafidi, 
& Schanberg, 1996).  Several therapies, including massage, have been demonstrated to help 
people increase brain activity from areas associated with anxiety and stress to areas associated 
with relaxation and alertness (Fox, 1991; Field et al., 1996).  For example, positive mood shifts 
were distinguished in changes from right frontal EEG activation, which is generally associated 
with sad affect, to left frontal EEG activation, which is typically associated with a happy affect.  
This shift in EEG was observed in both depressed mothers and their infants with anxiety, 
immediately following a 20-minute massage (Field et al., 1996).  To record participants EEG 
data a software computer screen was created that collected 6 minutes of baseline data and 30 
minutes of intervention, providing normative data and R/L brain alpha ratio scores.  The 
protocol utilized in this study for recording participants EEG was as follows: 
• Researcher located and marked F3, F4, and CZ placements using a 10/20 standard 
measurement cap. 
• Researcher prepped skin by cleaning connection sites using alcohol pads and Nuprep. 
• Researcher placed EEG sensors with #1s on the left and #2s on the right.  Active 
leads (red) were placed at F3 and F4.  Reference leads (black) were placed at CZ.  
The ground lead was placed on C7. 
• Researcher checked impedance to determine if it was at an acceptable level (between 
-25,000 and 25,000).  If not, sensors were adjusted or replaced until impedance was 
in an acceptable range. 




Heart Rate Variability (HRV) 
Recent research surrounding HRV use has indicated it to be a valid measure in viewing 
the relationship between anxiety and autonomic nervous system (ANS) activity (Friedman & 
Thayer 1998).  Heart rate variability data was collected using the Nexus-10 blood volume pulse 
(BVP) sensor, which was attached to participants’ non-dominant index finger and recorded for 
the duration of the intervention.  Heart rate variability is a standardized physiological 
measurement that directly reflects one’s ANS regulation.  Heart rate variability breaks the ANS 
down to smaller levels including the Sympathetic Nervous System (SNS) (stress, anxiety) and 
Parasympathetic Nervous System (PNS) (relaxation, calmness).  Cannon’s (1929) model noted 
that the hypothalamus was consistently activated when experiencing fear or anxiety, which leads 
to frequent activations of the SNS response.  Additionally, HRV changes indicated by increases 
in high frequency (PNS) and low frequency (SNS) norms and low/high frequency ratio will be 
used as specific indicators of stress and mood (Wilkinson et al., 1998; Davidson, 1988).  Data 
obtained was used to demonstrate if changes in the ANS are consistent with SNS withdrawal 
activity. 
Salivary Alpha Amylase (sAA) 
Use of sAA as a diagnostic tool and measurement has become increasingly popular 
across multiple healthcare fields including physiology, dentistry, and internal medicine (Mandel, 
1993; Rantonen, 2003).  This non-invasive standard allows for repeated measures of variables 
such as hormones, antibodies, and stress (Mandel, 1980; Mandel, 1990; Smith et al., 1991; 
Tabak, 2001; Rantonen, 2003).  By measuring saliva’s flow rate, viscosity, proteins, and 
amylase specific changes that have taken place both during the initial session, post-intervention, 
and after the training protocol can be demonstrated.  Participants gave a sAA sample pre and 
post intervention for session 1 and session 2.  Salivary alpha amylase has been demonstrated in 
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previous studies that as SNS activity increases so does secretion and as PNS activity increases so 
does flow rate (Yamaguchi et al, 2003).  During both physical and psychological stressors, 
increases in sAA have been recorded (Yamaguchi et al, 2003).   
Demographic Profile 
Participants also completed a demographic profile, which included pertinent demographic 
information.  Information included was gender, race, educational status, occupational status, 
and amount of time spent playing video games in the last week. Information gathered was 
helpful in describing the population as well as if they have any gaming experience. 
Log Sheet 
 Participants in the experimental group completed a log sheet during the one-month period 
between sessions.  Information included the title of their CVG, amount of sessions played, and 
amount of time played per session.  Information obtained from the log sheet was used to ensure 
that participants met minimum requirements for the intervention. 
Analysis Plan 
Data analysis was performed using PASW Statistics software (version 18).  The level of 
significance was set at .05.  For statistical analysis a two-way mixed ANOVA was administered 
to determine what times had a significant change, which included both time and group as factors.  
This ANOVA allowed testing of hypotheses regarding changes in time within each group, as 







CHAPTER IV:  RESULTS 
The purpose of this study was to determine the effects of casual video games (CVGs) 
when used as a prescribed intervention in reducing symptoms of anxiety in a depressed 
population.  Anxiety prevalence statistics estimate that in the United States general population 
approximately 40 million (18.1%) adults have an anxiety disorder (National Institute of Mental 
Health, 2010b).  The instrument used to test the research questions was the State Trait Anxiety 
Inventory (STAI).  To determine which times had a significant change, a two-way mixed 
ANOVA was utilized that included both time and group as factors.  The level of significance 
was set at 0.05.  A Mann-Whitney U test was used to determine if any covariates were 
significant.  None of the covariates examined revealed significance except for medications (p = 
0.013).  A Multivariate Analysis of Variance (MANOVA) that adjusted for medications was 
used to determine if there were group differences that would impact the outcome of the data.  
Results from the MANOVA revealed that medications did not impact the significance of the 
group differences observed between the experimental and control groups. 
Sample Description 
 Participants included in the study were individuals classified with clinical depression that 
was categorized by the PHQ-9, between the ages of 18-74.  There were a total of 59 participants 
in the study.  A total of 85 people were screened for inclusion into the study with 26 not 
meeting the entrance criteria, representing a rejection rate of 44%.  There were 30 females and 
29 males included in the study.  Participants in the experimental group ranged in age from 
18-56 with a mean age of 29, while participants in the control group ranged in age from 18-74 
with a mean age of 31.  Ethnic origins of respondents from the experimental group was reported 
to be 70% European American, 26.7% African American, and 3.3% Asian/Pacific Islander.  
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Participants in the control group ethnic origins was reported to be 65.5% European American, 
20.7% African American, 6.9% Latino American, and 6.9% Other.   
Marital status of respondents from the experimental group was reported to be 26.7% 
married, 13.3% separated, 6.7% divorced, and 53.3% never married.  Participants in the control 
group marital status was reported to be 35.7% married, 3.6% separated, 3.6% divorced, and 
57.1% never married.  Educational level for participants from the experimental group was 
reported to be 23.3% high school graduate, 40.0% some college, 20.0% college graduate, and 
16.7% post graduate.  Participants in the control group education level was reported to be 6.9% 
high school graduate, 55.2% some college, 24.1% college graduate, and 13.8% post graduate.  
Occupation status for respondents in the experimental group was reported to be 10.0% part-time, 
53.3% full-time, 3.3% disabled, 30.0% student, and 3.3% retired.  Respondents in the control 
group occupation status was reported to be 13.8% part-time, 34.5% full-time, 13.8% 
unemployed, 3.4% disabled, 3.4% homemaker, 27.6% student, and 3.4% retired.   
Participants in the experimental group reported that 56.7% had played a video game in 
the previous week and 40.0% had not.  Participants in the control group reported that 75.9% 
had played a video game in the previous week and 24.1% had not.  Respondents in the 
experimental group reported that 13.3% were utilizing antidepressant medications while 86.7% 
were not using any type of medication.  Respondents in the control group reported that 34.5% 
were utilizing antidepressant medications while 65.5% were not.  Participants in the 
experimental group log sheet revealed that the experimental group played their CVG of choice 
three times a week for 30 minutes minimum, 68 minutes maximum, and an average 40.7 minutes 
per week over the one-month period.   
Participants in the experimental group had a mean score of 11.0 on the PHQ-9 depression 
screener.  Participants in the control group had a mean score of 10.7 on the PHQ-9 depression 
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screener.  Baseline state anxiety scores on the STAI for respondents in the experimental group 
was 38, while trait anxiety scores were 42.  Baseline state anxiety scores on the STAI for 
respondents in the control group was 42, while trait anxiety scores were 47. 
Quantitative Results 
Data Collection Times 
The STAI data collection method followed administrative guidelines outlined in Chapter 
3.  State anxiety refers to a transitory emotional state or condition that can be characterized by 
subjective, consciously apparent feelings of tension and apprehension, and an amplified 
autonomic nervous system (Spielberger, 1985).  Conversely, trait anxiety refers to an 
individual’s proneness for anxiety and a common tendency to respond with anxiety when 
confronted with a perceived threat (Spielberger, 1985).  The state anxiety scale, which was 
created for short-term use was administered pre and post session 1 and session 2 and the trait 
anxiety scale was administered pre session 1 and pre session 2.   
Data collected at Time 1, initial baseline, was gathered before randomizing participants 
into either a control or experimental group.  Data collected during Time 2, post session 1, was 
completed at the end of the first session.  Data collected at Time 3, pre session 2, took place 
one-month post the initial baseline and prior to the beginning of session 2.  Time 4, post session 
2, was collected at the end of session 2.  The experimental and control groups had the same data 
collected at matching times and sessions. 
Results 
Hypothesis 1: 
Ho1:  There will be no significant difference in state anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
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Table 2  
Between Group Test for State Anxiety         
Group     N     Mean Std. Error Mean Difference F    p  
Experimental  30     32.04   1.82     −7.94  9.7 0.003 
Control  29     39.98   1.78      7.94  9.7 0.003  
 
Table 3 
Between Group Test for State Anxiety at Time 1, Time 2, Time 3, and Time 4    
Time  Group    Group  Mean Difference  Std. Error   p  
  1 Control       Experimental  3.28      3.0  0.275 
  2 Control       Experimental  8.48      2.7       0.003 
  3 Control       Experimental  8.34      3.1  0.009 
  4 Control       Experimental           11.64      2.7  0.000  
 
Overall there was a significant difference between the experimental and control groups 
for state anxiety scores, p = 0.003, and can be seen in Table 2.  However, this statistic includes 
all measurement times and, therefore, did not reveal where changes took place. In order to 
determine which times had a significant change a two-way mixed ANOVA was utilized that 
included both time and group as factors.  This repeated measures ANOVA provided the 
statistical analysis needed to test additional hypotheses regarding changes over time within each 
group, as well as, to examine group differences at each of the time points.   
Analysis revealed positive significant changes in state anxiety scores between the 
experimental and control group at specific measurement times, which is demonstrated by lower 
state anxiety scores, and can be seen in Table 3.  At Time 1, initial baseline, there was not a 
significant difference between the experimental and control groups state anxiety scores.  At 
Time 2, post session 1, there was a significant difference between the experimental and control 
groups state anxiety scores demonstrating the short-term effect of the game.  At Time 3, pre 
session 2, there was a significant difference between the experimental and control groups state 
anxiety scores demonstrating a decrease in anxiety symptoms after one-month of game play.  
Additionally, at Time 4, post session 2, there was a significant difference between the 
experimental and control groups state anxiety scores.   
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Table 4 
Pairwise Comparisons for State Anxiety         
Experimental Time Time  N      Mean Difference  Std. Error   p  
  1   2  30     6.44    1.35  0.000  
  1   3  30     7.67    1.73  0.000  
              3   4  30     2.22    1.49  0.142  
Control             
  1   2  29     1.25    1.33  0.351  
  1   3  29     2.61    1.70  0.131  
              3   4  29    −1.07    1.46  0.467  
 
Further analysis revealed a significant change over time took place in the experimental 
group, F (3, 51) = 13.1, p < 0.001.  The mean difference was significant between Time 1 and 
Time 2, demonstrating a significant short-term change and between Time 1 and Time 3, 
demonstrating a significant difference between experimental and control groups following 
one-month of game play.  However, there was not a significant mean difference between Time 
3 and Time 4. 
Analysis revealed that there was no statistically significant change over time in the 
control group, F (3, 51) = 0.8, p = 0.48.  Furthermore, none of the mean differences examined 
demonstrated a significant difference. 
Hypothesis 2: 
Ho2:  There will be no significant difference in trait anxiety symptom severity scores as 
measured by the STAI between the experimental and control groups. 
Table 5 
Between Group Test for Trait Anxiety         
Group   N     Mean Std. Error Mean Difference F  p  
Experimental  30     41.63   2.17     −5.50  3.2 0.078 
Control  29     47.13   2.17      5.50  3.2 0.078  
 
Overall there was no statistically significant difference between the experimental and 
control groups for trait anxiety scores, p = 0.078, failing to reject the null hypothesis (see Table 
5).  However, the p-value was near significance level so additional analyses were completed.  
Given the trend towards significance, a secondary analysis using Cohen’s Delta, a measure of 
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effect size that standardizes the difference between groups, was administered to determine the 
size of change between pre and post means (Cronk, 2008).  The analysis indicated that there 
was medium effect size of 0.45.  
At Time 1, initial baseline, there was not a statistically significant difference between the 
experimental and control groups trait anxiety scores (see Table 6).  At Time 3, pre session 2, 
there was a significant difference between the experimental and control groups trait anxiety 
scores, demonstrating change over a one-month period.  A significant decrease in trait anxiety 
scores is equated with lower levels of general anxiety experienced by participants in the 
experimental group (Spielberger, 1983). 
Table 6 
Between Group Test for Trait Anxiety at Time 1 and Time 3       
Time  Group  Group   Mean Difference        Std. Error       p  
  1 Control   Experimental  3.14      3.2   0.333 
  3 Control   Experimental       7.86      3.2   0.019  
 
Further analysis revealed a significant change over time took place in the experimental 
group (see Table 7).  A significant change in trait anxiety scores in the experimental group is 
indicative of a decrease in trait anxiety.  Analysis revealed that there was no significant change 
over time in the trait anxiety scores of the control group (see Table 7).  
Table 7 
Pairwise Comparisons for Trait Anxiety         
Experimental Time Time  N   Mean Difference    Std. Error      p  
             1   3  30  6.89      1.44     0.000  
Control             
             1   3  29  2.18      1.44     0.135  
 
 
Summary of Results 
 The results of this randomized controlled clinical study determined the significance of 
certain CVGs in terms of effectiveness of reducing anxiety symptoms.  Data obtained in this 
study supports the hypotheses that prescribed CVG play is consistent with reductions in anxiety 
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symptom severity.  For the experimental group significant changes were demonstrated pre and 
post game play session, as well as, before and after the month, which supports both the short and 
long term efficacy of prescribed CVG play to decrease both state and trait anxiety scores. 
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CHAPTER V:  DISCUSSION 
Anxiety disorders affect approximately 40 million Americans and can directly impact the 
level of an individual’s quality of life (National Institutes of Mental Health, 2010b).  The 
purpose of this study was to determine the effects of casual video games (CVGs) when used as a 
prescribed intervention in reducing symptoms of anxiety in a depressed population.  From a 
practical perspective, if it is true, as the data indicate, playing a specific game under a prescribed 
condition can reduce anxiety.  Therefore, the use of CVGs by healthcare practitioners, such as 
recreational therapists, may be an effective intervention. 
This research utilized a randomized controlled study design to compare state and trait 
anxiety scores among an experimental and control group at separate times.  All participants 
were screened using the Brief Patient Health Questionnaire-9 (PHQ-9) and met the criteria score 
for inclusion, which was a score equal to or greater than 5.  There were 85 people screened with 
26 not meeting the entrance criteria, representing a rejection rate of 44%.  A total of 59 
participants were included in the study.  The control group, consisting of 29 participants, 
engaged in a web-based review of the National Institutes of Mental Health’s web page on 
depression.  The experimental group, consisting of 30 participants, engaged in the use of CVGs 
as an intervention. 
In addition to the two lab sessions that were scheduled one month apart, the experimental 
group was required to play their chosen game at home for a minimum of 30 minutes, 3 times a 
week for one month.  Results demonstrated that the experimental group’s state and trait anxiety 
scores significantly decreased, indicating a reduction in state and trait anxiety symptom severity 
when compared to the control group scores. 
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Discussion of Findings 
In this study, state anxiety of the experimental group was significantly reduced after 
individual sessions, as well as when compared to the control group at one month.  In addition, 
trait anxiety was significantly reduced when the experimental group was compared to the control 
group at the end of the month long study. 
The results indicate that the CVGs demonstrated both short term (after 30 minutes of 
game play) and one-month statistically significant improvements in STAI scores when compared 
to the control group.  Participant log sheets reflected compliance as prescribed CVGs were 
played three times a week for 30 minutes minimum, 68 minutes maximum, and an average 40.7 
minutes.  This positive level of compliance with the prescribed regimen is not typical of other 
treatment interventions for anxiety disorders, and is a key benefit of this type of intervention 
(Osterberg & Blaschke, 2005).   
Implications 
The results from this study demonstrate the intrinsic value of CVGs in significantly 
reducing anxiety scores.  The data support the hypothesis that prescribed CVGs can affect 
anxiety symptom severity and as a result have practical health applications. 
Recreational therapists and other rehabilitation disciplines have been using video games 
to help patients with physical rehabilitation.  For example, Madonna Rehabilitation Hospital 
uses the Wii and similar games as part of its Commission on Accreditation of Rehabilitation 
Facilities (CARF) accredited brain injury program.  Likewise, the American Therapeutic 
Recreation Association (2009) website states that “the unique feature of recreational therapy that 
makes it different from other therapies is the use of recreational modalities in the designed 
intervention strategies”.  Prescribed CVGs is a pure recreational modality that in this study has 
demonstrated effectiveness as an intervention to address a clinical condition.  Conversely, the 
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recreational therapy literature offers no efficacious data surrounding the use of CVGs as an 
intervention.  
Based on the data, it is recommended that recreational therapists could prescribe this type 
of CVG to clients who are experiencing an anxiety disorder.  Data indicate playing a CVG at 
the prescribed protocol of three times a week, 30 minutes per session, for four weeks is an 
efficacious treatment for reducing anxiety scores in clients.  It is suggested that professionals 
such as recreational therapists who are lacking efficacious interventions for video games use this 
methodology, offering professionals a way to provide an effective intervention to reduce anxiety. 
Prescribed CVGs can address anxiety symptoms and help clients with their mental health 
sustainability.  The uses of CVGs offer an efficacious, cost effective, structured, and 
measurable intervention.  For anxiety, the data suggest that many rehabilitation therapists could 
utilize CVGs with patients to decrease their anxiety symptoms.  For example, a physical 
therapist could use CVGs with a patient to help alleviate state anxiety that is experienced during 
treatment. 
In application, recreational therapists could utilize this intervention for a patient who is 
experiencing pre surgery state anxiety or for a patient who needs help with stress management.  
Additionally, recreational therapists could use CVGs as a prescriptive intervention in 
rehabilitation settings.  For example, CVGs could be utilized with a patient who has 
experienced a stroke and is having a difficult time coping.  Other examples include, utilizing 
CVGs with clients who are experiencing anxiety as a result of transitioning into a new 
environment, such as a nursing facility.  As a result, CVGs should be made accessible at mental 
health clinics, community centers, online medical sites, and given out by therapists as a means of 
intervention for individuals experiencing anxiety. 
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Recommendations for Future Research 
 To further test the efficacious use of CVGs as an intervention, future research should 
investigate the effectiveness of CVGs with other drugs and as an adjunct to medicine and other 
therapies.  Traditional anxiety medications and therapies have had compliance issues and 
unfortunate side effects, such as nausea, jitters, addiction, and/or sexual dysfunction (National 
Institutes of Mental Health, 2009).  When trying to combat anxiety, these side effects and 
compliance problems may in turn increase an individual’s anxiety.  Therefore, future research 
should examine more proactive interventions, such as prescribed CVGs, as an efficacious, 
accessible, less invasive, and cost effective strategy for addressing anxiety.  A research study 
comparing CVGs with medicine is logically one next step in examining the efficacy of its 
utilization. 
 Another study recommendation is to examine different frequencies, intensities, and 
durations of prescribed CVG play.  The results of the present study demonstrated that a 
prescribed CVG utilized for 30 minutes, three times a week, for one month was effective; 
however, researchers should examine various frequencies, intensities, and durations, such as the 
number of times played during the week, how many minutes per session, and length of time.  
Additionally, researchers should examine different types of CVGs utilizing these prescribed 
protocols.  These results could help demonstrate what is the most efficacious prescription of 
CVGs in reducing individual’s anxiety levels. 
 Given differences observed in characteristics of the experimental and control groups, 
future research should examine these disparities.  Results from such a study would allow for an 
increased understanding of who benefits most from the use of CVGs as a treatment.  
Furthermore, to determine CVGs effectiveness as a treatment future research should control for 
covariates such as level of anxiety, education level, medication use, and computer use. 
	  44 
Given the results, persons who suffer from anxiety should be given access to this type of 
intervention, especially given CVGs cost and accessibility.  Moreover, individuals experiencing 
anxiety should be given the opportunity to utilize such an intervention, specifically due to 
increased compliance rates and no known side effects (Osterberg & Blaschke, 2005).  When 
compared to traditional treatments, this non-invasive treatment may be more cost-effective and 
perhaps overall more effective in reducing anxiety. 
Based on the issues that many individuals with anxiety experience it is recommended that 
CVGs as a valid treatment for individuals with anxiety be further investigated. 
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APPENDIX C: RECRUITMENT FLIER 
 
 
NEEDED:  Participants  for  a  research  study  to  determine  if  
playing  video  games  can  improve  symptoms  of  depression.   
-­  If  you  are  selected  and  complete  the  study  you  will  receive  3    video  games  (valued  at    
            $60.00).    
-­  If  you  are  not  selected  you  will  still  receive  one  free  video  game  (valued  at  $20.00)  
  
Participants  who  meet  the  criteria  will  be  placed  into  one  of  two  groups:  
  
Group  I:  Attend  two  sessions  approximately  90  minutes  each  
   EACH  SESSION  REQUIRES  PARTICIPANT  TO:  
   1.  Complete  written  pre-­assessments,  saliva  sample  and  record  physical  changes  using  sensors    
   2.  Record  physical  changes  for  30  minutes  while  participant  browses  NIMH  website  on    
           depression  
   3.  Complete  written  post-­assessments  and  saliva  sample    
   4.  Return  after  1  month  and  repeat  steps  1-­3  and  receive  3  video  games??????????????????    
  
Group  II:  Attend  two  sessions  approximately  90  minutes  each    
   EACH  SESSION  REQUIRES  PARTICIPANT  TO:  
   1.  Complete  written  pre-­assessments,  saliva  sample  and  record  physical  changes  using  sensors    
   2.  Record  physical  changes  for  30  minutes  while  participant  plays  video  game    
   3.  Complete  written  post-­assessments  and  saliva  sample    
   4.  Receive  1  video  game  to  play  at  home  3x  a  week  for  30  minutes  during  the  next  month  
   5.  Return  after  1  month  and  repeat  steps  1-­3  and  receive  other  2  video  games  ?????????????????
If  you  are  interested  in  participating  please  contact  Mr.  Matthew  Fish,  BCIAC  or  Dr.  Carmen  Russoniello    
at  252-­328-­0876  or  252-­328-­0024  or  by  email:  fishm04@students.ecu.edu  or  russonielloc@ecu.edu.    
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APPENDIX D: DEMOGRAPHIC SHEET 
 
Demographic / Clinical Data Collection Sheet 
Study ID #:______________________ 
Interview Date:______________________ Age:_________ 
Gender:____ (1=Male, 2=Female) 
 
4. Racial Background: 
1= White/European American 
2= Latino/Latina 
3= Black/African American 
4= Asian/Pacific Islander 
5= American Indian/Alaska Native 
6= Other 
 
5. Educational Status: 
1= 8th grade or less 
2= some high school 
3= high school graduate 




6. Occupational Status: 
1= Employed part time 






If employed, how many hours per week:______ 
 





5= Never married 
 
How many hours did you spend playing video games in the last week? 
1= 12 or more hours 
2=8 to 11 hours 
3=4 to 7 hours 
















APPENDIX G: STATE TRAIT ANXIETY INVENTORY COPYRIGHT PERMISSION 
 
May 24, 2010  
 
Mr. Matthew Taft Fish 
Psychophysiology & Biofeedback Clinic 
East Carolina University 
 
Dear Mr. Fish: 
 
In response to your recent request, I am very pleased to give you permission to reproduce and 
use the State-Trait Anxiety Inventory (STAI) in your Masters Thesis research, entitled: 
 
A randomized controlled study of the effectiveness  
of casual video games in reducing symptoms of anxiety. 
 
 
It is my understanding that your research will be carried out at:  
 
In a private secure room in the Belk Building. 
 
This permission is contingent on your agreement to share your findings with us when your 
research is completed.  I look forward to receiving further information about your procedures 
and the results of your study as this information becomes available.   
 







Charles D. Spielberger, Ph.D., ABPP  
Distinguished Research Professor of Psychology  
Director, Center for Research in Behavioral  
   Medicine and Health Psychology 
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